Literature DB >> 8500346

Comparison of the antiproliferative effects of colon mitosis inhibitor, thyroliberin and the somatostatin analog octreotide on rat colonic mucosal epithelial cells.

M Pawlikowski1, G Zerek-Melen, K Winczyk, H Stepien, A Lachowicz, A Janecka.   

Abstract

The effects of colon mitosis inhibitor (CMI), thyroliberin (TRH), and the somatostatin analogue octreotide (SMS 201-995) on rat colonic mucosal epithelial cell proliferation were studied. As an index of cell proliferation the incorporation of bromodeoxyuridine (BrDU) into cell nuclei was used. It was found that all three peptides inhibited the colonic mucosal epithelial cells proliferation, but the time course of inhibition was different. The effect of SMS 201-995 occurred 12 h after the peptide injection, while CMI and TRH suppressed the proliferation after 24 h. These observations suggest that the mechanisms of the antiproliferative actions of somatostatin and of related tripeptides CMI and TRH are different.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500346

Source DB:  PubMed          Journal:  Cytobios        ISSN: 0011-4529


  3 in total

1.  Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease.

Authors:  H Yamamoto; K Morise; K Kusugami; A Furusawa; T Konagaya; Y Nishio; H Kaneko; K Uchida; H Nagai; T Mitsuma; H Nagura
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

3.  Effects of TRH and TRH-like peptide pGLU-HIS-GLY-NH(2) on adrenocortical cell proliferation in rats.

Authors:  G Zerek-Mełeń; M Pawlikowski
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.